Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281
Shandong Keyuan Pharmaceutical Co Ltd
Inventory
Shandong Keyuan Pharmaceutical Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281
|
Inventory
¥128.9m
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Inventory
¥2.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Inventory
¥653.5m
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Inventory
¥6.2B
|
CAGR 3-Years
38%
|
CAGR 5-Years
24%
|
CAGR 10-Years
21%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Inventory
¥2.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
10%
|
CAGR 10-Years
17%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Inventory
¥162.2m
|
CAGR 3-Years
25%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
Shandong Keyuan Pharmaceutical Co Ltd
Glance View
Shandong Keyuan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical raw materials, and chemical preparation. The company is headquartered in Jinan, Shandong. The company went IPO on 2023-04-04. The firm's main products include gliclazide, metformin hydrochloride, ropivacaine hydrochloride and others. The firm's products are used in hypoglycemic, anesthetic, cardiovascular and psychiatric diseases. The firm conducts its operations mainly in the domestic market.
See Also
What is Shandong Keyuan Pharmaceutical Co Ltd's Inventory?
Inventory
128.9m
CNY
Based on the financial report for Dec 31, 2024, Shandong Keyuan Pharmaceutical Co Ltd's Inventory amounts to 128.9m CNY.
What is Shandong Keyuan Pharmaceutical Co Ltd's Inventory growth rate?
Inventory CAGR 3Y
14%
Over the last year, the Inventory growth was 19%. The average annual Inventory growth rates for Shandong Keyuan Pharmaceutical Co Ltd have been 14% over the past three years .
